AI assistant
Sending…
NEOGENOMICS INC — Director's Dealing 2021
Jun 5, 2021
32227_dirs_2021-06-04_223413a2-7723-4c1a-8d61-93e94ee73b4b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-06-02
Reporting Person: HANNAH ALISON L. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-02 | Common Stock | A | 3081 | — | Acquired | 91877 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-02 | Stock Option (Right to Buy) | $40.9 | A | 3714 | Acquired | 2028-06-02 | Common Stock (3714.0) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $11.6 | 2023-06-01 | Common Stock (3017.0) | 3017 | Direct |
| Stock Option (Right to Buy) | $22.52 | 2026-06-06 | Common Stock (4269.0) | 4269 | Direct |
| Stock Option (Right to Buy) | $28.54 | 2027-05-28 | Common Stock (3448.0) | 3448 | Direct |
More from NEOGENOMICS INC
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24